A Succinate Ether Derivative of Tocotrienol Enhances Dickkopf-1 Gene Expression through Epigenetic Alterations in Malignant Mesothelioma Cells
| Autor: | Kakeru Kohno, Momoka Fusegi, Saki Kaneko, Haruka Ueno, Tomohiro Yano, Yuko Sekine, Akira Ando, Nantiga Virgona, Ayami Sato |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Mesothelioma Methyltransferase Lung Neoplasms Cell Survival Gene Expression Apoptosis Epigenesis Genetic 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Cell Line Tumor Cyclin D Humans Epigenetics DNA (Cytosine-5-)-Methyltransferases RNA Small Interfering Pharmacology Gene knockdown Chemistry Cell growth Tocotrienols Mesothelioma Malignant Wnt signaling pathway JNK Mitogen-Activated Protein Kinases Membrane Proteins Sodium butyrate General Medicine DNA Methylation Cell biology Histone Deacetylase Inhibitors 030104 developmental biology 030220 oncology & carcinogenesis DNA methylation Intercellular Signaling Peptides and Proteins Chromatin immunoprecipitation |
| Zdroj: | Pharmacology. 102(1-2) |
| ISSN: | 1423-0313 |
| Popis: | Background: Wnt signaling plays an essential role in tumor cell growth, including the development of malignant mesothelioma (MM). Epigenetic silencing of negative Wnt regulators leading to constitutive Wnt signaling has been observed in various cancers and warrants further attention. We have reported that a succinate ether derivative of α-tocotrienol (T3E) has potent cytotoxic effects in MM cells. Thus, in this study, we investigated whether the anti-MM effect of T3E could be mediated via the epigenetic alteration of the Wnt antagonist gene, Dickkopf-1 (DKK1). Methods: WST-1 and cell analyzers were employed to analyze the effects of T3E on cell viability and apoptosis of human MM cell lines (H2452, H28). Real-time PCR and Western blot were performed to evaluate the expression at mRNA and protein levels. Methylation status and epigenetic modifications of DKK1’s promoter regions after T3E treatment in MM cells were studied using methylation-specific PCR and Chromatin immunoprecipitation. Small interfering RNA-mediated knockdown (siRNA), and specific inhibitors, were used to validate DKK1 as a target of T3E. Results: T3E markedly impaired MM cell viability, increased the expression of phosphorylated-JNK and DKK1 and suppressed cyclin D, a downstream target gene of Wnt signaling. Knockdown of DKK1 expression by siRNA or a specific JNK inhibitor confirmed the contribution of DKK1 and JNK to T3E-induced cytotoxicity in MM cells. On the other hand, cytoskeleton-associated protein 4 (CKAP4) expression, which promotes cell proliferation as a Wnt-independent DKK1 receptor was inhibited by T3E. Silencing CKAP4 by siRNA did not appear to directly affect MM cell viability, thereby indicating that expression of both DKK1 and CKAP4 is required. Furthermore, T3E-mediated inhibition of both DNA methyltransferases (DNMT1, 3A, and 3B) and histone deacetylases (HDAC1, 2, 3, and 8) in MM cells leads to increased DKK1 expression, thereby promoting tumor growth inhibition. MM cells treated with Zebularine (a DNMT inhibitor) and sodium butyrate (an HDAC inhibitor) exhibited cytotoxic effects, which may explain the inhibitory action of T3E on MM cells. In addition, an enhanced expression of DKK1 in MM cells following T3E treatment is positively correlated with the methylation status of its promoter; T3E decreased DNA methylation and increased histone acetylation. Moreover, T3E specifically increased histone H3 lysine 4 (H3K4) methylation activity, whereas no effects were observed on histone H3K9 and H3K27. Conclusions: Targeting the epigenetic induction of DKK1 may lead to effective treatment of MM, and T3E has great potential to induce anti-MM activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|